Matrix metalloproteinases and cardiovascular diseases.

Area of Science:

• Biochemistry
• Cardiology
• Molecular Biology

Background:

• Matrix metalloproteinases (MMPs) are extracellular enzymes crucial for physiological and pathological processes.
• Tissue inhibitors of metalloproteinases (TIMPs) are the primary regulators of MMPs activity.
• MMP expression is linked to cardiovascular risk factors and inflammation.

Purpose of the Study:

• To review the existing literature on the role of MMPs and TIMPs in cardiovascular diseases.
• To explore the influence of common cardiovascular medications on MMPs activity.

Main Methods:

• Literature review of studies investigating MMPs, TIMPs, and cardiovascular disease.
• Analysis of research on the effects of antihypertensives, glitazones, and statins on MMPs.

Main Results:

• MMPs are implicated in key cardiovascular conditions including atherosclerosis, plaque formation, and acute coronary syndrome.
• Inflammation and cardiovascular risk factors are associated with altered MMPs expression.
• Certain medications, including statins and antihypertensives, may modulate MMPs activity.

Conclusions:

• MMPs and TIMPs are significant factors in the pathogenesis of cardiovascular disease.
• Understanding the interplay between MMPs, inhibitors, and medications is vital for cardiovascular health management.